Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma
- 1 November 1973
- Vol. 32 (5), 1131-1140
- https://doi.org/10.1002/1097-0142(197311)32:5<1131::aid-cncr2820320519>3.0.co;2-n
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Lymphocytotoxic Antibodies In Prostatic CancerJAMA, 1971
- Chemotherapy in Urologic Cancer**The patients treated by the author are part of a continuing study under the auspices of the Veterans Administration Urological Research Group in Collaboration with the Clinical Branch, Collaborative Research, National Cancer Institute, Public Health Service.Surgical Clinics of North America, 1965
- Clinical Cancer of the ProstateJAMA, 1965
- CyclophosphamideJAMA, 1963
- Five Years Clinical Experience with 5-FluorouracilJAMA, 1962
- Meaningful clinical classification of therapeutic responses to anticancer drugsClinical Pharmacology & Therapeutics, 1961
- Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide)Cancer, 1960
- Nitrogen mustard therapy: Clinical studies on the effects of methyl-bis (beta-chloroethyl) amine hydrochloride upon various types of neoplastic diseaseThe American Journal of Surgery, 1949
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948
- TREATMENT OF PROSTATIC CANCER: WITH α-BROMO-α.β.β-TRIPHENYLETHYLENE (Y59)The Lancet, 1947